These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22669118)

  • 1. Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy.
    Wang YH; Wang L; Lu W; Shang DW; Wei MJ; Wu Y
    Acta Pharmacol Sin; 2012 Jun; 33(6):845-51. PubMed ID: 22669118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of valproate in Chinese children with epilepsy.
    Jiang DC; Wang L; Wang YQ; Li L; Lu W; Bai XR
    Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Population pharmacokinetics of lamotrigine in Chinese children with epilepsy].
    Zhang S; Wang L; Lu W
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):105-9. PubMed ID: 18433522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy.
    Zhang ZB; Ji SM; Han Y; Zang LL; Wang YH; Lu W; Wang L; Wu Y
    Eur J Clin Pharmacol; 2017 Apr; 73(4):445-453. PubMed ID: 28064355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
    Toublanc N; Sargentini-Maier ML; Lacroix B; Jacqmin P; Stockis A
    Clin Pharmacokinet; 2008; 47(5):333-41. PubMed ID: 18399714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.
    He DK; Wang L; Qin J; Zhang S; Lu W; Li L; Zhang JM; Bao WQ; Song XQ; Liu HT
    Acta Pharmacol Sin; 2012 Nov; 33(11):1417-23. PubMed ID: 23103620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.
    Wang Y; Zhang HN; Niu CH; Gao P; Chen YJ; Peng J; Liu MC; Xu H
    Acta Pharmacol Sin; 2014 Oct; 35(10):1342-50. PubMed ID: 25220641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
    Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
    Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
    Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy.
    Hernández-Mitre MP; Medellín-Garibay SE; Rodríguez-Leyva I; Rodríguez-Pinal CJ; Zarazúa S; Jung-Cook HH; Roberts JA; Romano-Moreno S; Milán-Segovia RDC
    J Pharm Sci; 2020 Jun; 109(6):2070-2078. PubMed ID: 32113977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
    Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
    J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
    Peng J; Zhang HN; Liu ZS; Xu H; Wang Y
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):684-92. PubMed ID: 24887335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of levetiracetam in Japanese and Western adults.
    Pigeolet E; Jacqmin P; Sargentini-Maier ML; Stockis A
    Clin Pharmacokinet; 2007; 46(6):503-12. PubMed ID: 17518509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic model of valproate and prediction of valproate serum concentrations in children with epilepsy.
    Jiang DC; Wang L
    Acta Pharmacol Sin; 2004 Dec; 25(12):1576-83. PubMed ID: 15569400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and comedications influence levetiracetam pharmacokinetics in children.
    Dahlin MG; Wide K; Ohman I
    Pediatr Neurol; 2010 Oct; 43(4):231-5. PubMed ID: 20837299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an integrated population pharmacokinetic model for oral levetiracetam in populations of various ages and ethnicities.
    Toublanc N; Lacroix BD; Yamamoto J
    Drug Metab Pharmacokinet; 2014; 29(1):61-8. PubMed ID: 23877106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of levetiracetam in neonates with seizures.
    Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
    J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.